New Proteomic Map Reveals How Cancer Metabolism Rewires T Cell Proteins, Opening Immunotherapy Targets
核心洞察
Researchers at Rockefeller University created the first comprehensive map showing how energy-producing metabolite changes alter proteins controlling T cell activity in cancer.
The study identified SLC33A1 (搜索) as a key protein that regulates oxidative stress in the endoplasmic reticulum, acting as a "pressure release valve" for cells.
Pancreatic cancer (搜索) cells carrying high antioxidant levels may be particularly vulnerable to therapies targeting SLC33A1 (搜索), though human efficacy remains unproven.
A landmark study from Rockefeller University has produced the first comprehensive atlas of how changes in a cell's energy-producing molecules directly alter the proteins that govern T cell function, revealing a previously hidden mechanism by which cancer may evade the immune system.
"Cancer can wear down the immune system's T cells, making them less effective at attacking tumors," said Ekaterina Vinogradova, head of the laboratory of chemical immunology and proteomics at Rockefeller University. "Using chemical proteomic approaches, we created the first comprehensive map showing how changes in a cell's energy-producing molecules affect the proteins that control T cell activity."
The findings, published in 2026, represent a collaboration between Vinogradova's proteomics laboratory and the laboratory of metabolic regulation and genetics led by Kivanç Birsoy at Rockefeller. Together, the two labs are systematically mapping how cancer cells' altered metabolism changes the shape and function of proteins throughout the cell — extending far beyond the traditional view of metabolism as simply a fuel-production system.
Beyond Energy: Metabolism as a Protein Regulator
For decades, cancer metabolism research focused primarily on how tumor cells rewire nutrient breakdown to generate energy and building blocks for rapid growth. The Rockefeller team's work fundamentally expands this framework by demonstrating that the small molecules produced during metabolism — metabolites — can directly control how proteins work across the entire proteome.
Birsoy's team has built specialized tools to examine metabolism inside specific cellular compartments, including mitochondria, lysosomes, and the Golgi apparatus. Vinogradova's lab developed mass spectrometry techniques capable of tracking chemical changes across thousands of proteins simultaneously, capturing shifts caused by oxidation, structural alterations, and modified interactions with other molecules.
The collaboration initially set out to study oxidative stress but soon realized their tools could also track how metabolites bind directly to proteins across the entire proteome. This insight launched an effort to build a full reference atlas showing how individual metabolites affect protein behavior — a map that could help distinguish different causes of protein changes in cancer.
SLC33A1 (搜索): A Cellular Pressure Release Valve
The team's first major discovery centered on the endoplasmic reticulum (ER), the cellular structure where proteins are built and folded. They identified a protein called SLC33A1 (搜索) that helps maintain ER balance by removing oxidized glutathione when levels climb too high.
Dr. Brian Honeyman, a clinical adviser at Marietta Springs who was not involved in the study, described SLC33A1 (搜索) as "one important cell level pressure release valve." He explained that losing SLC33A1 causes oxidized glutathione to accumulate in the endoplasmic reticulum, damaging protein-folding enzymes and forcing the cell to rely more heavily on its quality-control systems.
"The key finding is that metabolism is not just about supplying energy to cancer cells but also about changing the chemical state of proteins through metabolite changes," Honeyman said. "This provides a more specific link between abnormal metabolic states and cellular behavior for cancer research."
Pancreatic Cancer (搜索) and Future Therapeutic Directions
The team is now applying its proteomic mapping tools to pancreatic cancer (搜索), a disease with few effective treatments. Because pancreatic cancer cells tend to carry high levels of antioxidants such as glutathione, Birsoy suggested that SLC33A1 (搜索) could represent a promising drug target.
However, Honeyman cautioned that the findings do not yet constitute proof of a treatment. The study did not demonstrate that boosting SLC33A1 (搜索) shrinks tumors, blocks metastasis, or improves survival in humans. "I view this as a mapping of previously unknown cellular circuitry, rather than a direct new therapy," he said, adding that the work nonetheless shows how a metabolic imbalance can ripple into the protein-folding machinery, creating openings for future treatments.
The research underscores a broader shift in cancer biology: metabolites are not merely fuel but also critical signaling molecules that can push cells toward or away from malignancy. By revealing the specific molecular bridges between metabolism and protein function, the Rockefeller team's atlas may guide the development of a new generation of cancer immunotherapies targeting these previously hidden regulatory nodes.